Altered RNA editing in 3′ UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Liye ^a   Yang, Chih Sheng ^a   Varelas, Xaralabos ^a   Monti, Stefano ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; MDM2 PROTEIN, HUMAN; MICRORNA; PROTEIN MDM2; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; BINDING SITE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; ONCOGENE; PHYSIOLOGY; RNA EDITING; RNA INTERFERENCE; SEQUENCE ANALYSIS; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; ONCOGENES; PROTO-ONCOGENE PROTEINS C-MDM2; RNA EDITING; RNA INTERFERENCE; SEQUENCE ANALYSIS, RNA; TUMOR SUPPRESSOR PROTEINS;

EID: 84961132008     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23226     Document Type: Article

References (53)

1. Nishikura, K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79, 321-349 (2010)
2. Chester, A.; Scott, J.; Anant, S. & Navaratnam, N. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA. Biochim Biophys Acta 1494, 1-13 (2000)
3. Wang, I. X.; So, E.; Devlin, J. L.; Zhao, Y.; Wu, M. & Cheung, V. G. ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep 5, 849-860 (2013)
4. Nemlich, Y. et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest 123, 2703-2718 (2013)
5. Galeano, F. et al. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene 32, 998-1009 (2013)
6. Gallo, A. & Galardi, S. A-to-I RNA editing and cancer: from pathology to basic science. RNA Biol 5, 135-139 (2008)
7. Paz, N. et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 17, 1586-1595 (2007)
8. Chen, L. et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19, 209-216 (2013)
9. Li, M. et al. Widespread RNA and DNA sequence differences in the human transcriptome. Science 333, 53-58 (2011)
10. Pugh, T. J. et al. The genetic landscape of high-risk neuroblastoma. Nat Genet 45, 279-284 (2013)
11. Ramaswami, G. & Li, J. B. RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res 42, D109-113 (2014)
12. Zilberman, D. E. et al. Does RNA editing play a role in the development of urinary bladder cancer? Urologic oncology 29, 21-26 (2011)
13. Galeano, F. et al. Human BLCAP transcript: new editing events in normal and cancerous tissues. International journal of cancer Journal international du cancer 127, 127-137 (2010)
14. Han, L. et al. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer cell 28, 515-528 (2015)
15. Paz-Yaacov, N. et al. Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors. Cell Rep 13, 267-276 (2015)
16. Peng, Z. et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol 30, 253-260 (2012)
17. Ramaswami, G.; Lin, W.; Piskol, R.; Tan, M. H.; Davis, C. & Li, J. B. Accurate identification of human Alu and non-Alu RNA editing sites. Nature methods 9, 579-581 (2012)
18. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43, 491-498 (2011)
19. Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012)
20. Cabanski, C. R. et al. BlackOPs: increasing confidence in variant detection through mappability filtering. Nucleic Acids Res 41, e178 (2013)
21. Picardi, E. & Pesole, G. REDItools: high-throughput RNA editing detection made easy. Bioinformatics 29, 1813-1814 (2013)
22. Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298-303 (2011)
23. Cancer Genome Atlas, N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576-582 (2015)
24. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22, 568-576 (2012)
25. McIntyre, L. M. et al. RNA-seq: technical variability and sampling. BMC Genomics 12, 293 (2011)
26. Farrell, C. M. et al. Current status and new features of the Consensus Coding Sequence database. Nucleic Acids Res 42, D865-872 (2014)
27. Hochberg, M. et al. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes. Archives of dermatological research 305, 519-528 (2013)
28. Flomen, R.; Knight, J.; Sham, P.; Kerwin, R. & Makoff, A. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res 32, 2113-2122 (2004)
29. Laurencikiene, J.; Kallman, A. M.; Fong, N.; Bentley, D. L. & Ohman, M. RNA editing and alternative splicing: the importance of co-transcriptional coordination. EMBO reports 7, 303-307 (2006)
30. Rueter, S. M.; Dawson, T. R. & Emeson, R. B. Regulation of alternative splicing by RNA editing. Nature 399, 75-80 (1999)
31. Gu, T.; Buaas, F. W.; Simons, A. K.; Ackert-Bicknell, C. L.; Braun, R. E. & Hibbs, M. A. Canonical A-to-I and C-to-U RNA editing is enriched at 3? UTRs and microRNA target sites in multiple mouse tissues. PloS one 7, e33720 (2012)
32. Liang, H. & Landweber, L. F. Hypothesis: RNA editing of microRNA target sites in humans? Rna 13, 463-467 (2007)
33. Forbes, S. A. et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 38, D652-657 (2010)
34. Adams, B. D.; Kasinski, A. L. & Slack, F. J. Aberrant regulation and function of microRNAs in cancer. Current biology : CB 24, R762-776 (2014)
35. Djuranovic, S.; Nahvi, A. & Green, R. A parsimonious model for gene regulation by miRNAs. Science 331, 550-553 (2011)
36. Guo, H.; Ingolia, N. T.; Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840 (2010)
37. Zhao, Y.; Yu, H. & Hu, W. The regulation of MDM2 oncogene and its impact on human cancers. Acta biochimica et biophysica Sinica 46, 180-189 (2014)
38. Yang, Y. M. et al. Galpha12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma. Oncogene 34, 2910-2921 (2015)
39. Avesson, L. & Barry, G. The emerging role of RNA and DNA editing in cancer. Biochim Biophys Acta 1845, 308-316 (2014)
40. Anadon, C. et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene, doi: 10. 1038/onc. 2015. 469 (2015)
41. Ramaswami, G. et al. Identifying RNA editing sites using RNA sequencing data alone. Nature methods 10, 128-132 (2013)
42. Park, E.; Williams, B.; Wold, B. J. & Mortazavi, A. RNA editing in the human ENCODE RNA-seq data. Genome Res 22, 1626-1633 (2012)
43. Bazak, L. et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res 24, 365-376 (2014)
44. Karreth, F. A. et al. The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo. Cell 161, 319-332 (2015)
45. Gerstberger, S.; Hafner, M. & Tuschl, T. A census of human RNA-binding proteins. Nature reviews Genetics 15, 829-845 (2014)
46. Trapnell, C.; Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009)
47. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009)
48. Jeggari, A.; Marks, D. S. & Larsson, E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 28, 2062-2063 (2012)
49. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010)
50. Lagana, A. et al. miR-EdiTar: a database of predicted A-to-I edited miRNA target sites. Bioinformatics 28, 3166-3168 (2012)
51. Hiemer, S. E. et al. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma. Molecular cancer research : MCR 13, 957-968 (2015)
52. Piskol, R.; Peng, Z.; Wang, J. & Li, J. B. Lack of evidence for existence of noncanonical RNA editing. Nat Biotechnol 31, 19-20 (2013)
53. Varani, G. & McClain, W. H. The G x U wobble base pair. A fundamental building block of RNA structure crucial to RNA function in diverse biological systems. EMBO reports 1, 18-23 (2000)